Findings on Disease Progression Reported by Investigators at Dartmouth College Geisel School of Medicine (Alternating 17b-estradiol and Aromatase Inhibitor Therapies Is Efficacious In Postmenopausal Women With Advanced Endocrine-resistant Er...).
In: Women's Health Weekly, 2023-09-12, S. 409-409
serialPeriodical
Zugriff:
Alternating 17(3-estradiol/AI therapy may be a promising treatment for endocrine-refractory ER+ breast cancer, including following progression on CDK4/6 inhibitors or everolimus." Keywords: Lebanon; State:New Hampshire; United States; North and Central America; Aromatase; Aromatase Inhibitors; Breast Cancer; Cancer; Cytochromes; Disease Attributes; Disease Progression; Drugs and Therapies; Endocrine Research; Endocrinology; Enzyme Inhibitors; Enzymes and Coenzymes; Estradiol Congeners; Estradiol Therapy; Estrogen; Estrogens; Gonadal Hormones; Health and Medicine; Hemeproteins; Hormone Replacement Therapy; Hormones; Mixed Function Oxygenases; Oncology; Oxidoreductases; Oxygenases; Pharmaceuticals; Sex Hormones; Steroid Hydroxylases; Therapy; Vaginal Agents; Vaginal Preparations; Women's Health EN Lebanon State:New Hampshire United States North and Central America Aromatase Aromatase Inhibitors Breast Cancer Cancer Cytochromes Disease Attributes Disease Progression Drugs and Therapies Endocrine Research Endocrinology Enzyme Inhibitors Enzymes and Coenzymes Estradiol Congeners Estradiol Therapy Estrogen Estrogens Gonadal Hormones Health and Medicine Hemeproteins Hormone Replacement Therapy Hormones Mixed Function Oxygenases Oncology Oxidoreductases Oxygenases Pharmaceuticals Sex Hormones Steroid Hydroxylases Therapy Vaginal Agents Vaginal Preparations Women's Health 409 409 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on Disease Attributes - Disease Progression have been presented. [Extracted from the article]
Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Findings on Disease Progression Reported by Investigators at Dartmouth College Geisel School of Medicine (Alternating 17b-estradiol and Aromatase Inhibitor Therapies Is Efficacious In Postmenopausal Women With Advanced Endocrine-resistant Er...).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2023-09-12, S. 409-409 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Sonstiges: |
|